KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Current Assets (2016 - 2025)

Opko Health's Current Assets history spans 16 years, with the latest figure at $581.9 million for Q4 2025.

  • For Q4 2025, Current Assets fell 12.11% year-over-year to $581.9 million; the TTM value through Dec 2025 reached $581.9 million, down 12.11%, while the annual FY2025 figure was $581.9 million, 12.11% down from the prior year.
  • Current Assets reached $581.9 million in Q4 2025 per OPK's latest filing, down from $627.1 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $823.0 million in Q4 2021 to a low of $309.5 million in Q4 2023.
  • Average Current Assets over 5 years is $533.1 million, with a median of $552.3 million recorded in 2021.
  • Peak YoY movement for Current Assets: plummeted 52.06% in 2022, then surged 113.94% in 2024.
  • A 5-year view of Current Assets shows it stood at $823.0 million in 2021, then tumbled by 52.06% to $394.5 million in 2022, then decreased by 21.56% to $309.5 million in 2023, then soared by 113.94% to $662.1 million in 2024, then fell by 12.11% to $581.9 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Current Assets are $581.9 million (Q4 2025), $627.1 million (Q3 2025), and $583.3 million (Q2 2025).